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We compared ChromID Strepto B agar (STRB; bioMe´rieux, Inc.), a selective and differential medium for
group B streptococcus, with culture using neomycin-nalidixic acid agar (NNA) and LIM broth. STRB alone was
more sensitive (87.7%) than NNA alone (79.0%), while each had a sensitivity of 100% when used in conjunction
with LIM broth.
Meningitis, pneumonia, and septicemia due to group B
Streptococcus (GBS) infection are leading causes of infant
mortality and morbidity (7). In 1996 the American College of
Obstetricians and Gynecologists (ACOG) and the CDC issued
recommendations for intrapartum antibiotic prophylaxis ac-
cording to either a risk-based or a screening-based approach to
prevent GBS transmission to neonates. The risk-based guide-
lines called for intrapartum prophylaxis in the event of delivery
at 37 weeks of gestation, a temperature of 100.4°F, or the
rupture of membranes for 18 h, while the culture-based ap-
proach called for the screening of all pregnant women between
35 and 37 weeks of gestation for vaginal or rectal colonization
with GBS and subsequent intrapartum prophylaxis of those
who were culture positive. In 2002 these guidelines were re-
vised to recommend that culture-based prenatal GBS screen-
ing at 35 to 37 weeks of gestation be universally adopted (8).
This time point was chosen as an appropriate predictor of
intrapartum colonization (11). U.S. national estimates of early-
onset (7 days of life) neonatal invasive GBS disease using
data collected by the CDC Active Bacterial Core Surveillance
system (ABCs) indicate a decrease in incidence since the in-
stitution of GBS screening and prophylaxis guidelines, from 0.7
case/1,000 live births in 1997 to 0.34 case/1,000 live births in
2007 (3).
The CDC and ACOG recommend that vaginal/rectal swabs
be inoculated into a selective broth medium to aid in the
recovery of GBS. The broth is then to be subcultured on sheep
blood agar plates after 18 to 24 h of incubation (1, 8). The
addition of a solid agar medium inoculated upon receipt of the
swab in the laboratory can allow for the identification of GBS
after 24 h of incubation, instead of the 48 h required when
swabs are inoculated only into selective broth. Neomycin-na-
lidixic acid agar (NNA) medium is a GBS-selective solid agar
that can be used for primary plating, since it is significantly
more sensitive than colistin-nalidixic acid agar (CNA) for this
purpose (4). However, NNA should never be used as a substi-
tute for a selective broth medium, because the combination of
a selective broth medium and NNA improves the detection of
GBS by 15% over that with either medium used alone (5).
ChromID Strepto B agar (STRB; bioMe´rieux, Inc.) is a
newly developed selective and differential medium for the pre-
sumptive identification of GBS. STRB contains a chromogenic
substrate that, in the presence of actively growing GBS, gen-
erates pink to red colonies that are easily identified during
routine inspection. The growth of bacteria of other species
either is inhibited or appears in other colors (violet, blue, or
colorless). We evaluated the performance of STRB in our
laboratory compared to that of NNA, with or without the
addition of a selective broth medium, as a suitable screening
method for the detection of GBS colonization among pregnant
women.
Our established protocol calls for the inoculation of vaginal/
rectal swabs onto NNA, which is incubated at 35°C under 5%
CO2, and into LIM broth, which is incubated at 35°C in room
air. The NNA plate is examined at 24 h for the presence of
characteristic beta-hemolytic colonies, which are further eval-
uated by Gram staining and by catalase, PYR (pyrrolidonyl--
naphthylamide), and rapid latex agglutination tests to identify
GBS. If beta-hemolytic colonies are not present after 24 h of
incubation, then (i) the NNA plate is held for an additional
24 h and is examined the following day, and (ii) the LIM broth
is subcultured onto 5% sheep blood agar, which is incubated
for 48 h and is examined daily for the presence of beta-hemo-
lytic colonies. To evaluate the performance of the STRB agar,
primary swabs were processed by our routine protocol and
were also inoculated onto the STRB plate, which was incu-
bated at 35°C for 48 h in the dark. A single swab was collected
from each patient, and the order of inoculation onto STRB or
NNA plates was randomized. Plates were examined daily for
the presence of pink colonies, which were then subjected to
latex agglutination testing to confirm the identification of GBS.
Gram staining and catalase and latex agglutination testing can
be performed directly from STRB agar, while PYR testing
cannot. However, according to the manufacturer, the appear-
ance of pink to red colonies that type as group B by latex
agglutination is sufficient for the identification of GBS.
A total of 250 prenatal screening swabs were included in the
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study. Eighty-one of these samples (32.4%) were positive for
GBS by our reference method (i.e., they were recovered from
either NNA or LIM broth). The sensitivity, specificity, positive
predictive value (PPV), and negative predictive value (NPV) of
either combination (NNA plus LIM broth subcultured onto
5% sheep blood agar or STRB plus LIM broth subcultured
onto 5% sheep blood agar) were all 100%. A direct compari-
son of NNA to STRB without broth amplification as a screen-
ing medium revealed sensitivities of 79.0% (95% confidence
interval [95% CI], 68.3% to 86.9%) for NNA and 87.7% (95%
CI, 78.0% to 93.6%) for STRB (Table 1). For both NNA and
STRB, the specificity was 97.6% (95% CI, 93.8% to 99.3%),
with four isolates being incorrectly identified as group B Strep-
tococcus. The four isolates from NNA were identified as Strep-
tococcus porcinus, while three of the four S. porcinus isolates
from NNA were also incorrectly identified on STRB, along
with a fourth isolate that was identified as Streptococcus tho-
raltensis. There is some potential for misidentification of other
streptococcal species as GBS by using STRB. S. porcinus iso-
lated from NNA would likely be evaluated further if a wide
zone of beta-hemolysis, which is not characteristic of GBS,
were recognized. This would not be the case, however, if iso-
lates were identified from STRB alone, since there would be
no potential to observe the hemolysis pattern. Conversely,
GBS can exhibit a nonhemolytic phenotype that may be over-
looked on NNA, but these isolates would be identified using
chromogenic agar (10).
Several recent publications have assessed the use of molec-
ular methods for GBS screening. Real-time PCR for GBS has
not proven to be sufficiently sensitive to replace culture-based
screening (2, 9). An evaluation of a nonamplified nucleic acid
hybridization assay indicated that in order to achieve a sensi-
tivity similar to that of culture, the sample must be incubated
in LIM broth for 24 h before molecular testing (9), thereby
negating the potential advantage of a rapid testing methodol-
ogy. El Helali et al. report good performance (sensitivity,
98.5%; specificity, 99.6%) for a rapid real-time PCR test for
GBS in comparison to culture on Columbia ANC sheep blood
agar and broth medium (6). However, the authors’ suggestion
that current guidelines for antenatal testing may not be rele-
vant due to the low PPV of antenatal screening (58.3%) was
based on a comparison of PCR, not to culture of intrapartum
samples in broth medium and Columbia ANC agar, but to
culture of antenatal samples on Columbia ANC agar alone, not
to culture of intrapartum samples in broth medium and Co-
lumbia ANC agar (6). The use of Columbia ANC agar alone
without the addition of a selective broth medium to screen the
antenatal samples would lead to decreased sensitivity and
would likely cause a falsely low PPV.
In conclusion, we report that STRB used in combination
with LIM broth performs as well as NNA with LIM broth and
that chromogenic agar has a higher sensitivity than NNA. The
95% confidence intervals of the sensitivities of STRB or NNA
culture alone overlap, indicating that there is not a significant
difference between these two culture methods. However, chro-
mogenic agar has advantages: the ease of detecting a color
change on this medium, as opposed to looking for weakly
beta-hemolytic colonies on NNA, and the need to perform only
one additional test from STRB medium. The rare chance of a
false-positive result is balanced by the increased sensitivity of
STRB and the potential for detecting nonhemolytic colonies of
GBS. real-time PCR (RT-PCR) may provide an alternative to
culture in situations where a result is needed before culture can
be completed (i.e., birth at 37 weeks of gestation, or lack of
appropriate prenatal care and screening), though this would
likely not be a cost-effective alternative to routine antenatal
testing.
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TABLE 1. Performance characteristics of STRB,









STRB 71 87.7 97.6
NNA 64 79.0 97.6
LIM 74 91.4 100
LIM or STRB 81 100 100
LIM or NNA 81 100 100
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